Skip to main content

Steve Rotman

Steve Rotman has over thirty years of experience in the practice of law. For the last ten years his practice has focused on pharmaceutical product liability litigation. Prior to that his practice encompassed personal injury, product liability, constitutional law litigation, and commercial litigation, both on the defense and plaintiff sides. He has experience with trials in state and federal courts, with AAA arbitrations, mediations, and appeals in state and federal courts. He has tried alone or with others, three pharmaceutical products cases, two medical malpractice cases, a medical device case, several construction cases, and several commercial cases.

Over the course of his career, Steve has concentrated on pharmaceutical product liability litigation, representing plaintiffs who suffered devastating injuries or loss of life from unreasonably dangerous drugs. He has served (and currently serves) on discovery and science committees, or performed common benefit work in several pharmaceutical and medical device multi-district litigations. (e.g.., In re Zofran Products Liability Litigation; In re: Phenylpropanolamine (PPA) Products Liability Litigation; Pradaxa Products Liability Litigation; In re Hormone Replacement Therapy Litigation; In re Fresenius Granuflo/Naturalyte Dialysate Products Liability Litigation;Mirena IUD Products Liability Litigation; and In re Diet Drugs).

In the PPA litigation (decongestants associated with hemorrhagic stroke) (2000-2006), Steve was principally responsible for the MDL general causation Daubert briefing and general causation expert witness work. He took multiple depositions of defense liability witnesses and MDL causation experts in the fields of epidemiology and stroke neurology.

More Less